Ophthalmic Eye Drops Franchise in Ahmedabad

Ophthalmic Eye Drops Franchise in Ahmedabad

Antibiotic Steroid Eye Drops Supplier in Mumbai

Ophthalmic Product Manufacturer in Bangalore

Eye Care Medicine Stockist in Hyderabad
Ophthalmic Product Exporter in Chandigarh

Home/Products /moxifloxacin-0-point-5-w-v-dexamethasone-0-point-1-w-v-eye-ear-drop

About the Product

Description


Moxifloxacin 0.5% + Dexamethasone 0.1% Eye Drops are used for the treatment of bacterial ocular infections associated with inflammation, including conjunctivitis and postoperative eye conditions.

Moxifloxacin, a broad-spectrum fluoroquinolone antibiotic, works by inhibiting bacterial DNA synthesis, while dexamethasone, a potent corticosteroid, helps reduce inflammation, redness, pain, and swelling.

This combination is commonly prescribed in infective-inflammatory eye conditions where both microbial control and anti-inflammatory action are required for faster recovery and improved patient comfort.

Due to its dual-action benefits and strong demand in ophthalmic practice, this formulation supports consistent prescriptions, enhances treatment confidence, and helps attract more customers through reliable clinical performance and visible therapeutic results.

Common side effects may include transient burning sensation, eye irritation, blurred vision, or redness. Rarely, prolonged use may increase intraocular pressure, delay wound healing, or cause secondary infections.

Moxolunic D Eye Drops are indicated for steroid-responsive inflammatory ocular conditions with suspected or confirmed bacterial infection, including conjunctivitis, blepharitis, post-operative eye inflammation, and other bacterial eye infections as advised by an ophthalmologist.

For ophthalmic use only. Use strictly under medical supervision. Avoid touching the dropper tip to prevent contamination. Prolonged or improper use may increase the risk of glaucoma or cataract formation. Discontinue use and consult an eye specialist if vision changes or severe irritation occur.

Store below 25°C in a cool, dry place. Protect from light. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v Eye/Ear Drops in the PCD pharma franchise market?

Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v Eye/Ear Drops have strong demand in the ophthalmology, ENT, and anti-infective segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on eye care and ear care portfolios.

Why should medical distributors include Moxifloxacin + Dexamethasone Eye/Ear Drops in their product range?

Medical distributors and agencies can benefit from consistent demand for ocular and otic infection management with associated inflammation under medical supervision. Moxifloxacin 0.5% w/v is a broad-spectrum fluoroquinolone antibiotic effective against a wide range of susceptible bacteria Dexamethasone 0.1% w/v is a corticosteroid that helps reduce inflammation, redness, swelling, and discomfort Commonly prescribed for bacterial eye infections, post-operative eye care, and selected ear infections accompanied by inflammation as advised by healthcare professionals Helps address both microbial infection and inflammatory symptoms through a dual-action approach Sterile eye/ear drop formulation ensures targeted local administration Frequently used in ophthalmology clinics, ENT practices, hospitals, and surgical care settings Widely prescribed by ophthalmologists, ENT specialists, and general physicians This strengthens a comprehensive ophthalmology and ENT care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v Eye/Ear Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand, steady retail and institutional sales, repeat purchases, reliable supply chain support, and attractive margins in the ophthalmic and ENT segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.